Search results
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...
KTLA-TV Los Angeles· 5 days agoIn these studies, bimekizumab consistently demonstrated sustained improvements...
Is TikTok’s #sunbedaddiction the most dangerous trend on social media today?
Harpers BAZAAR· 5 days agoTikTok beauty trends can span the good (heatless styling), the bad (sunscreen contouring) and the...
SRMC receives proclamation from Ohio Lt. Governor’s Liaison
Salem News· 6 days agoSALEM — On May 20, Mary Kate Hastings, NE Ohio Regional Liaison for Lt. Gov. Jon Husted, presented a...
Got Tiny Blood Vessels on Your Face? Here's Why, and How To Treat Them
Well and Good· 7 days agoMore often than not, those red, spider-like clusters are just...broken blood vessels. Broken blood...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 7 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 7 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Tracking down the genetic causes of lupus to personalize treatment
Medical Xpress· 5 days agoResearchers are just now beginning to link specific genetic mutations to subsets of lupus patients, allowing physicians to target therapies to those who will benefit most. In the latest advance ...
Healthcare's Hope in Artificial Intelligence
Medscape· 5 days agoAI is coming for healthcare, and that's a good thing.
Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split
KTLA-TV Los Angeles· 5 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
ETF DAILY NEWS· 3 days agoStock analysts at StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research report issued on Friday. The brokerage set a “hold” rating on the ...